Finance

Lists
CAPLIPOINT:NSE
Caplin Point Laboratories Ltd
₹2,575.00
+1.79%
(+45.30) 1D
Aug 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CAPLIPOINT...
Open
₹2,530.00
High
₹2,589.00
Low
₹2,516.30
Mkt. cap
195.41B
Avg. vol.
0.00
Volume
77.30K
Dividend
0.31%
Quarterly dividend
₹2.00
Ex-dividend date
May 29, 2026
P/E ratio
29.50
52-wk high
₹2,699.00
52-wk low
₹1,500.30
EPS
₹87.28
Shares outstanding
75.60M
No. of employees
4K
Open
₹2,530.00
High
₹2,589.00
Low
₹2,516.30
Mkt. cap
195.41B
Avg. vol.
0.00
Volume
77.30K
Dividend
0.31%
Quarterly dividend
₹2.00
Ex-dividend date
May 29, 2026
P/E ratio
29.50
52-wk high
₹2,699.00
52-wk low
₹1,500.30
EPS
₹87.28
Shares outstanding
75.60M
No. of employees
4K
About Caplin Point Laboratories Ltd
CEO-
Employees3.97K
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitecaplinpoint.net
Last report
Aug 12, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
6.10B / 5.79B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.34B
5.43B
6.00B
6.10B
Cost of goods sold
2.10B
2.15B
2.45B
2.45B
Cost of revenue
2.10B
2.15B
2.45B
2.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
472.30M
497.80M
526.20M
541.30M
Operating expense
1.53B
1.57B
1.70B
1.73B
Total operating expenses
3.63B
3.72B
4.15B
4.18B
Operating income
1.71B
1.70B
1.85B
1.92B
Other non operating income
303.70M
336.80M
283.60M
335.50M
EBT including unusual items
2.01B
2.04B
2.13B
2.25B
EBT excluding unusual items
2.01B
2.04B
2.13B
2.25B
Income tax expense
407.70M
380.30M
405.60M
461.30M
Effective tax rate
20.28%
18.65%
19.00%
20.48%
Other operating expenses
873.40M
881.60M
983.00M
975.50M
Net income
1.54B
1.64B
1.70B
1.77B
Net profit margin
28.92%
30.19%
28.34%
28.98%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.60M
-1.80M
-3.60M
-1.80M
Net interest expenses
-1.60M
-1.80M
-3.60M
-1.80M
Depreciation and amortization charges
184.00M
192.80M
188.00M
216.20M
EBITDA
1.88B
1.86B
2.04B
2.10B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps